Figure 2.
Cytokine differences among participants at study entry during active diagnoses of KICS with KS and PEL with or without KS from the KICS protocol, and KAD comparators from HAMB protocols at periods of active disease (KS alone and MCD with KS). HAMB, HIV and AIDS Malignancy Branch; ns, not significant.